Bosutinib is an advanced and superior medication often prescribed for leukemia patients with a common disorder namely chronic myelogenous leukemia. Bosutinib cost could always be deliberated from the viewpoint of access in different countries. It is known by its brand name Bosulif. It is frequently referred as Bosulif 500mg or Bosulif 400mg, denoting to the two different commercially accessible strengths. This medication is developed and marketed by Pfizer, a global pharmaceuticals major.
Bosulif – Approval by US FDA and EU EMA
Bosutinib received FDA approval in 2012 and EMA clearance in the year 2013. Unlike few other medications, this is promoted as one brand in all regions where it is accessible. Being an oral medication, it is also easy for patients to consume as per the standard prescribing guidelines. Cancer medicines available as tablets or capsules have better acceptance from the patients. Bosutinib price when it comes to the total cost of the therapy is determined by the treatment planning by the physician. Number of months recommended for treatment shall count.
- Bosutinib in the patients of chronic myelogenous leukemia is adequately supported by the clinical research data. There are ongoing clinical trials too which can make this medication more relevant.
- For newly diagnosed Ph+ CML patients, the dosage could be once daily Bosulif 400mg. Patients with resistance to prior therapy are recommended once daily Bosulif 500mg.
Bosutinib in India – Basic information about sourcing and procurement
Bosutinib or Bosulif in India is recommended as a preferred therapeutic option by Hematologists, subject to its access and availability. In India, many treating physicians or experts often prescribe drugs that may not be available in India. It is understandable that going online to try and get relevant information regarding Bosulif price or Bosulif cost in India. It is important for them to connect with genuine sources of import medicines. Before going in for an extensive search, it is also a better idea to consider the treating physician’s or hospital pharmacy’s advice. They can refer to the patients who already used similar medications that are yet to be approved or available in India.
It is legal for the Indian patients to import medicines for personal use under the specially designed provisions by the Indian authorities. The process of Named Patient import is not that complex. Therefore, it is better for patients to search and find the ideal sources without any panic when looking for Bosutinib in India. Contacting an experienced or seasoned distributor will help in securing the right Bosulif price in India.
Standard procedure for Bosulif in India import
Just like most of the advanced countries, India has specific procedures and regulations by CDSCO, an agency that also deals with import and export permits of medicines. They facilitate Import Permit process for legitimate purchase of Bosutinib in India. Patients are advised to procure the prescription from their treating physicians in the stipulated format. After procuring the import permit, it is very important for patients to ensure the authenticity of the prospective suppliers they are interacting with. It further helps in ensuring the right cost and access information is provided which can be validated independently. Your import services provider should be able to ensure uninterrupted supply within minimum timeframe, supporting in your treatment objectives. Contact Noel Biotech – +91 9677010046 / +91 992977766; nhs@noelbiotech.com